Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application
Qianwen Guan, Shuaishuai Xing, Lei Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7788-7824
Closed Access | Times Cited: 26
Anticancer Activity of Chalcones and Its Derivatives: Review and In Silico Studies
Fernando Ferreira Leite, Natália Ferreira de Sousa, Bruno Hanrry Melo de Oliveira, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4009-4009
Open Access | Times Cited: 25
Synthesis and In Vitro Antitumor Activity Evaluation of Gefitinib-1,2,3-Triazole Derivatives
Zijun Liu, Jiancheng Liu, Gao En, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 837-837
Open Access | Times Cited: 8
Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 28
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
Rasheid Smith, Emad I. Wafa, Sean M. Geary, et al.
Science Advances (2022) Vol. 8, Iss. 29
Open Access | Times Cited: 28
Chalcones and Gastrointestinal Cancers: Experimental Evidence
Radka Michalková, Martin Kello, Martina Čižmáriková, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5964-5964
Open Access | Times Cited: 17
Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6
Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5
Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1154-1154
Open Access | Times Cited: 5
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
Design, Synthesis, Anticancer Screening, and Mechanistic Study of Spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide Derivatives
Ahmed M. M. El‐Saghier, Hamada H. H. Mohammed, Sherif A. Maher, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 863-863
Open Access
Synthesis, characterization, anticancer potential and mechanisms of cytotoxic activity of phosphoramide derivatives; experimental and theoretical study
Khodayar Gholivand, Azam Barzegari, Marjan Ghorbani-Anarkooli, et al.
Inorganic Chemistry Communications (2025), pp. 113917-113917
Closed Access
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
Mechanistic Approach into 1,2,3-triazoles-based IIIM(S)-RS98 Mediated Apoptosis in Lung Cancer Cells
Rigzin Dolkar, Gourav Paudwal, Davinder Singh, et al.
The AAPS Journal (2025) Vol. 27, Iss. 1
Closed Access
Synthesis and biological evaluation of ciprofloxacin – 1,2,3-triazole hybrids as antitumor, antibacterial, and antioxidant agents
Samir Al-Taweel, Yousef M. Al-saraireh, Salah A. Al‐Trawneh, et al.
Heliyon (2023) Vol. 9, Iss. 12, pp. e22592-e22592
Open Access | Times Cited: 14
Ciprofloxacin Derivative‐Loaded Nanoparticles Synergize with Paclitaxel Against Type II Human Endometrial Cancer
Youssef W. Naguib, Suhaila O. Alhaj‐Suliman, Emad I. Wafa, et al.
Small (2023)
Open Access | Times Cited: 11
Recent updates in click and computational chemistry for drug discovery and development
Jiang Hong Cai, Xuan Zhe Zhu, Peng Yue Guo, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 10
Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents
Jiahui Yang, Jianmei Lv, Shuxian Cheng, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 11, pp. 1265-1283
Closed Access | Times Cited: 10
A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer
Suhaila O. Alhaj‐Suliman, Youssef W. Naguib, Emad I. Wafa, et al.
Biomaterials (2023) Vol. 296, pp. 122093-122093
Open Access | Times Cited: 10
Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3
Small-molecule drugs of colorectal cancer: Current status and future directions
Yiren Yang, Pengyu Liu, Mingyang Zhou, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166880-166880
Closed Access | Times Cited: 8
Synthesis, characterization, cytotoxic evaluation, and molecular docking studies of novel 1,2,3-triazole-based chalcones for potential anticancer applications
Venkateswarlu Banoji, A. Kishore Kumar, V. Sunitha, et al.
Results in Chemistry (2023) Vol. 7, pp. 101294-101294
Open Access | Times Cited: 8
The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 1
Semisynthesis of novel chalcone hybrid compounds linked by 1,2,3-triazole and evaluation of their cytotoxic effects
Yassine Laamari, Mourad Fawzi, Ali Oubella, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139648-139648
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top